News
2d
The Chosun Ilbo on MSNS. Korean companies join global race for obesity drugsAs the global obesity medication market skyrockets, South Korean pharmaceuticals are rushing to develop national obesity drugs. Currently, the global industry is dominated by GLP-1 (glucagon-like ...
Endocrinologist Dr Ambrish Mithal, the author of the recently-released book, The Weight Loss Revolution, talks to fitness and ...
The popular diabetes and weight-loss drug semaglutide may lower the risk of dementia when taken by Type 2 diabetes patients, new research from the Case Western Reserve School ...
DelveInsight’s Obesity pipeline report depicts a robust space with 80+ active players working to develop 100+ pipeline ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results